[Hopespringpcsg] FW: Participate in our survey about Xtandi!

Glen Tolhurst glen46nor at gmail.com
Wed Oct 8 14:05:12 EDT 2014


Hi all:

Plse see survey below.

Participate if you wish.

Thx.

Glen

 

From: Jackie Manthorne [mailto:jmanthorne at survivornet.ca] 
Sent: October 8, 2014 11:59 AM
To: Jackie Manthorne
Subject: Participate in our survey about Xtandi!

 

Dear Friends,

 

Please take a few moments of your time to participate in our survey about Xtandi and/or send it to friends, colleagues or fellow support group members.

 

The purpose of this survey is to provide the us with insights and perspectives about living with and managing metastatic prostate cancer from patients and caregivers in order to complete a patient evidence submission to the pan-Canadian Oncology Drug Review for enzalutamide (Xtandi) for the treatment of patients with metastatic castration-resistant prostate cancer (mPRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy who have not received prior chemotherapy.

This survey will be available starting now and remain open until October 13, 5 pm, 2014.

 

To access the survey, go to https://www.surveymonkey.com/s/JCXNYJH

We would like to thank you if you have already completed this survey, and invite those who haven't to participate now!

 

Best,

Jackie

-- 

Jackie Manthorne

President and CEO

Présidente et chef de la direction

Canadian Cancer Survivor Network

Réseau canadien des survivants du cancer

1750 croissant Courtwood Crescent, Suite 210

Otttawa, ON K2C 2B5

Telephone / Téléphone : 613-898-1871

E-mail / Courriel : jmanthorne at survivornet.ca

Web site / site web: www.survivornet.ca

Blog: http://jackiemanthornescancerblog.blogspot.com/

Twitter: @survivornet.ca

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20141008/631c13ab/attachment.html>


More information about the Hopespringpcsg mailing list